{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:34:03Z","timestamp":1783481643136,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:00:00Z","timestamp":1470873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11011-016-9892-0","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T23:02:07Z","timestamp":1470870127000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease"],"prefix":"10.1007","volume":"32","author":[{"given":"Thais C.","family":"Vilela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselli","family":"Scaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila B.","family":"Furlanetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus A. B.","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Gelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Cl\u00e1udio F.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia F.","family":"Schuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio L.","family":"Streck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"key":"9892_CR1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-0186(00)00100-5","volume":"38","author":"P Araujo","year":"2001","unstructured":"Araujo P, Wassermann GF, Tallini K, Furlanetto V, Vargas CR, Wannmacher CM, Dutra-Filho CS, Wyse AT, Wajner M (2001) Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38:529\u2013537","journal-title":"Neurochem Int"},{"key":"9892_CR2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305\u20131308","journal-title":"Science"},{"key":"9892_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clinbiochem.2007.11.015","volume":"41","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR (2008a) Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem 41:317\u2013324","journal-title":"Clin Biochem"},{"key":"9892_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11011-007-9077-y","volume":"23","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR (2008b) Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab Brain Dis 23:71\u201380","journal-title":"Metab Brain Dis"},{"key":"9892_CR5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.clinbiochem.2008.12.005","volume":"42","author":"AG Barschak","year":"2009","unstructured":"Barschak AG, Sitta A, Deon M, Busanello EN, Coelho DM, Cipriani F, Dutra-Filho CS, Giugliani R, Wajner M, Vargas CR (2009) Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Clin Biochem 42:462\u2013466","journal-title":"Clin Biochem"},{"key":"9892_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0736-5748(03)00074-1","volume":"21","author":"R Bridi","year":"2003","unstructured":"Bridi R, Araldi J, Sgarbi MB, Testa CG, Durigon K, Wajner M, Dutra-Filho CS (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327\u2013332","journal-title":"Int J Dev Neurosci"},{"key":"9892_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","volume":"20","author":"R Bridi","year":"2005","unstructured":"Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS (2005) alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis 20:155\u2013167","journal-title":"Metab Brain Dis"},{"key":"9892_CR8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jneumeth.2006.01.005","volume":"155","author":"R Bridi","year":"2006","unstructured":"Bridi R, Fontella FU, Pulrolnik V, Braun CA, Zorzi GK, Coelho D, Wajner M, Vargas CR, Dutra-Filho CS (2006) A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies. J Neurosci Methods 155:224\u2013230","journal-title":"J Neurosci Methods"},{"key":"9892_CR9","first-page":"1219","volume":"11","author":"J Brismar","year":"1990","unstructured":"Brismar J, Aqeel A, Brismar G, Coates R, Gascon G, Ozand P (1990) Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants. AJNR Am J Neuroradiol 11:1219\u20131228","journal-title":"AJNR Am J Neuroradiol"},{"key":"9892_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/smim.1996.0055","volume":"9","author":"AM Chinnaiyan","year":"1997","unstructured":"Chinnaiyan AM, Dixit VM (1997) Portrait of an executioner: the molecular mechanism of FAS\/APO-1-induced apoptosis. Semin Immunol 9:69\u201376","journal-title":"Semin Immunol"},{"key":"9892_CR11","first-page":"1971","volume-title":"The metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2001","unstructured":"Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1971\u20132005"},{"key":"9892_CR12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-4159.1992.tb09409.x","volume":"59","author":"PR Dodd","year":"1992","unstructured":"Dodd PR, Williams SH, Gundlach AL, Harper PA, Healy PJ, Dennis JA, Johnston GA (1992) Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem 59:582\u2013590","journal-title":"J Neurochem"},{"key":"9892_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","volume":"17","author":"FU Fontella","year":"2002","unstructured":"Fontella FU, Gassen E, Pulrolnik V, Wannmacher CM, Klein AB, Wajner M, Dutra-Filho CS (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47\u201354","journal-title":"Metab Brain Dis"},{"key":"9892_CR14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMra022366","volume":"348","author":"RM Friedlander","year":"2003","unstructured":"Friedlander RM (2003) Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 348:1365\u20131375","journal-title":"N Engl J Med"},{"key":"9892_CR15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0731-7085(97)00066-6","volume":"15","author":"E Holmes","year":"1997","unstructured":"Holmes E, Foxall PJ, Spraul M, Farrant RD, Nicholson JK, Lindon JC (1997) 750 MHz 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharm Biomed Anal 15:1647\u20131659","journal-title":"J Pharm Biomed Anal"},{"key":"9892_CR16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-113-28456","volume":"113","author":"RK Howell","year":"1963","unstructured":"Howell RK, Lee M (1963) Influence of alpha-ketoacids on the respiration of brain in vitro. Proc Soc Exp Biol Med 113:660\u2013663","journal-title":"Proc Soc Exp Biol Med"},{"key":"9892_CR17","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1042\/bst026s341","volume":"26","author":"P Jouvet","year":"1998","unstructured":"Jouvet P, Rustin P, Felderhoff U, Pocock J, Joashi U, Mazarakis ND, Sarraf C, Edwards AD, Mehmet H (1998) Maple syrup urine disease metabolites induce apoptosis in neural cells without cytochrome c release or changes in mitochondrial membrane potential. Biochem Soc Trans 26:S341","journal-title":"Biochem Soc Trans"},{"key":"9892_CR18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1749-6632.2000.tb05604.x","volume":"926","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Kozma M, Mehmet H (2000a) Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids. Ann N Y Acad Sci 926:116\u2013121","journal-title":"Ann N Y Acad Sci"},{"key":"9892_CR19","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","volume":"11","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Rustin P, Taylor DL, Pocock JM, Felderhoff-Mueser U, Mazarakis ND, Sarraf C, Joashi U, Kozma M, Greenwood K, Edwards AD, Mehmet H (2000b) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919\u20131932","journal-title":"Mol Biol Cell"},{"key":"9892_CR20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1471-4914(01)02017-2","volume":"7","author":"I Kanazawa","year":"2001","unstructured":"Kanazawa I (2001) How do neurons die in neurodegenerative diseases? Trends Mol Med 7:339\u2013344","journal-title":"Trends Mol Med"},{"key":"9892_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/00207459408986065","volume":"79","author":"J Korein","year":"1994","unstructured":"Korein J, Sansaricq C, Kalmijn M, Honig J, Lange B (1994) Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity. Int J Neurosci 79:21\u201345","journal-title":"Int J Neurosci"},{"key":"9892_CR22","first-page":"1693s","volume":"59","author":"SJ Korsmeyer","year":"1999","unstructured":"Korsmeyer SJ (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59:1693s\u20131700s","journal-title":"Cancer Res"},{"key":"9892_CR23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1976.tb04458.x","volume":"26","author":"JM Land","year":"1976","unstructured":"Land JM, Mowbray J, Clark JB (1976) Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease. J Neurochem 26:823\u2013830","journal-title":"J Neurochem"},{"key":"9892_CR24","first-page":"315","volume-title":"Branched chain amino and keto acids in health and disease","author":"U Langenbeck","year":"1984","unstructured":"Langenbeck U (1984) Pathobiochemical and pathophysiologic analysis of the MSUD phenotype. In: Adibi SA, Fekl W, Langenbeck U, Schauder P (eds) Branched chain amino and keto acids in health and disease. Karger, Basel, pp 315\u2013334"},{"key":"9892_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3476(05)83521-8","volume":"122","author":"ML Levin","year":"1993","unstructured":"Levin ML, Scheimann A, Lewis RA, Beaudet AL (1993) Cerebral edema in maple syrup urine disease. J Pediatr 122:167\u2013168","journal-title":"J Pediatr"},{"key":"9892_CR26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11011-011-9238-x","volume":"26","author":"C Mescka","year":"2011","unstructured":"Mescka C, Moraes T, Rosa A, Mazzola P, Piccoli B, Jacques C, Dalazen G, Coelho J, Cortes M, Terra M, Regla Vargas C, Dutra-Filho CS (2011) In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease. Metab Brain Dis 26:21\u201328","journal-title":"Metab Brain Dis"},{"key":"9892_CR27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.gene.2014.07.051","volume":"548","author":"CP Mescka","year":"2014","unstructured":"Mescka CP, Wayhs CA, Guerreiro G, Manfredini V, Dutra-Filho CS, Vargas CR (2014) Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro. Gene 548:294\u2013298","journal-title":"Gene"},{"key":"9892_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mrfmmm.2015.03.008","volume":"775","author":"CP Mescka","year":"2015","unstructured":"Mescka CP, Guerreiro G, Hammerschmidt T, Faverzani J, de Moura CD, Mandredini V, Wayhs CA, Wajner M, Dutra-Filho CS, Vargas CR (2015) L-Carnitine supplementation decreases DNA damage in treated MSUD patients. Mutat Res 775:43\u201347","journal-title":"Mutat Res"},{"key":"9892_CR29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","volume":"74","author":"ZN Oltvai","year":"1993","unstructured":"Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609\u2013619","journal-title":"Cell"},{"key":"9892_CR30","first-page":"370","volume":"39","author":"LC Ong","year":"1998","unstructured":"Ong LC, Khoo TB, Zulfiqar A, Zarida H, Ruzana A (1998) Computed tomography findings in maple syrup urine disease. Singapore Med J 39:370\u2013372","journal-title":"Singapore Med J"},{"key":"9892_CR31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1022876130038","volume":"28","author":"C Pilla","year":"2003","unstructured":"Pilla C, Cardozo RF, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem Res 28:675\u2013679","journal-title":"Neurochem Res"},{"key":"9892_CR32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1471-4159.1966.tb05882.x","volume":"13","author":"AL Prensky","year":"1966","unstructured":"Prensky AL, Moser HW (1966) Brain lipids, proteolipids, and free amino acids in maple syrup urine disease. J Neurochem 13:863\u2013874","journal-title":"J Neurochem"},{"key":"9892_CR33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11064-007-9423-9","volume":"33","author":"CA Ribeiro","year":"2008","unstructured":"Ribeiro CA, Sgaravatti AM, Rosa RB, Schuck PF, Grando V, Schmidt AL, Ferreira GC, Perry ML, Dutra-Filho CS, Wajner M (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33:114\u2013124","journal-title":"Neurochem Res"},{"key":"9892_CR34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-3476(05)81036-4","volume":"119","author":"JJ Riviello Jr","year":"1991","unstructured":"Riviello JJ Jr, Rezvani I, DiGeorge AM, Foley CM (1991) Cerebral edema causing death in children with maple syrup urine disease. J Pediatr 119:42\u201345","journal-title":"J Pediatr"},{"key":"9892_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ymgme.2012.04.009","volume":"106","author":"G Scaini","year":"2012","unstructured":"Scaini G, Jeremias IC, Morais MO, Borges GD, Munhoz BP, Leffa DD, Andrade VM, Schuck PF, Ferreira GC, Streck EL (2012) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106:169\u2013174","journal-title":"Mol Genet Metab"},{"key":"9892_CR36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","volume":"82","author":"S Schonberger","year":"2004","unstructured":"Schonberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69\u201375","journal-title":"Mol Genet Metab"},{"key":"9892_CR37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2003.09.010","volume":"1639","author":"AM Sgaravatti","year":"2003","unstructured":"Sgaravatti AM, Rosa RB, Schuck PF, Ribeiro CA, Wannmacher CM, Wyse AT, Dutra-Filho CS, Wajner M (2003) Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232\u2013238","journal-title":"Biochim Biophys Acta"},{"key":"9892_CR38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s002340050597","volume":"40","author":"M Steinlin","year":"1998","unstructured":"Steinlin M, Blaser S, Boltshauser E (1998) Cerebellar involvement in metabolic disorders: a pattern-recognition approach. Neuroradiology 40:347\u2013354","journal-title":"Neuroradiology"},{"key":"9892_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(00)00402-0","volume":"181","author":"RG Tavares","year":"2000","unstructured":"Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, Dutra-Filho CS (2000) Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181:44\u201349","journal-title":"J Neurol Sci"},{"key":"9892_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01800354","volume":"15","author":"E Treacy","year":"1992","unstructured":"Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15:121\u2013135","journal-title":"J Inherit Metab Dis"},{"key":"9892_CR41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.38.3.486","volume":"38","author":"G Uziel","year":"1988","unstructured":"Uziel G, Savoiardo M, Nardocci N (1988) CT and MRI in maple syrup urine disease. Neurology 38:486\u2013488","journal-title":"Neurology"},{"key":"9892_CR42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1054\/jocn.2001.1027","volume":"9","author":"FJ Vajda","year":"2002","unstructured":"Vajda FJ (2002) Neuroprotection and neurodegenerative disease. J Clin Neurosci 9:4\u20138","journal-title":"J Clin Neurosci"},{"key":"9892_CR43","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1242\/dev.124.6.1239","volume":"124","author":"K Vekrellis","year":"1997","unstructured":"Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J (1997) Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 124:1239\u20131249","journal-title":"Development"},{"key":"9892_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.10.1.1","volume":"10","author":"E White","year":"1996","unstructured":"White E (1996) Life, death, and the pursuit of apoptosis. Genes Dev 10:1\u201315","journal-title":"Genes Dev"},{"key":"9892_CR45","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1046\/j.1471-4159.1994.63041508.x","volume":"63","author":"M Yudkoff","year":"1994","unstructured":"Yudkoff M, Daikhin Y, Nissim I, Pleasure D, Stern J, Nissim I (1994) Inhibition of astrocyte glutamine production by alpha-ketoisocaproic acid. J Neurochem 63:1508\u20131515","journal-title":"J Neurochem"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-016-9892-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-016-9892-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-016-9892-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-016-9892-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T19:08:57Z","timestamp":1657048137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-016-9892-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["9892"],"URL":"https:\/\/doi.org\/10.1007\/s11011-016-9892-0","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]}}}